Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Imiquimod for Anal HPV Lesions
NCT03289260Phase 3Unknown
- Sponsor
- Medical University of Innsbruck
- Start
- Nov 2021
- Primary completion
- Nov 2024
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of imiquimod in condyloma acuminatum, sponsored by Medical University of Innsbruck. Status: unknown.
02
Drugs
imiquimod
03
Conditions
condyloma acuminatum
Beyond the preview
Go deeper on NCT03289260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03289260.